These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 8217057

  • 1. Effect of diazepam on muscle weakness in a model of myasthenia gravis in rats.
    Molenaar PC, Van Kempen GT.
    J Neural Transm Gen Sect; 1993; 93(3):181-5. PubMed ID: 8217057
    [Abstract] [Full Text] [Related]

  • 2. Effect of ephedrine on muscle weakness in a model of myasthenia gravis in rats.
    Molenaar PC, Biewenga JE, Van Kempen GT, De Priester JA.
    Neuropharmacology; 1993 Apr; 32(4):373-6. PubMed ID: 8497338
    [Abstract] [Full Text] [Related]

  • 3. Acetylcholinesterase activity of skeletal muscle in a non-immunogenic model for myasthenia gravis in rats.
    Van Kempen GT, Trip SA, Molenaar PC.
    J Neural Transm (Vienna); 1999 Apr; 106(5-6):423-31. PubMed ID: 10443548
    [Abstract] [Full Text] [Related]

  • 4. Anti-acetylcholine receptor antibodies directed against the alpha-bungarotoxin binding site induce a unique form of experimental myasthenia.
    Gomez CM, Richman DP.
    Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4089-93. PubMed ID: 6575398
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Decreased number of acetylcholine receptors is the mechanism that alters the time course of muscle relaxants in myasthenia gravis: a study in a rat model.
    De Haes A, Proost JH, De Baets MH, Stassen MH, Houwertjes MC, Wierda JM.
    Eur J Anaesthesiol; 2005 Aug; 22(8):591-6. PubMed ID: 16119595
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Thymopoietin and myasthenia gravis: neostigmine-responsive neuromuscular block produced in mice by a synthetic peptide fragment of thymopoietin.
    Goldstein G, Schlesinger DH.
    Lancet; 1975 Aug 09; 2(7928):256-9. PubMed ID: 49801
    [Abstract] [Full Text] [Related]

  • 16. Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis.
    Lindstrom JM, Einarson BL, Lennon VA, Seybold ME.
    J Exp Med; 1976 Sep 01; 144(3):726-38. PubMed ID: 182896
    [Abstract] [Full Text] [Related]

  • 17. A hypothesis to account for the Mary Walker phenomenon.
    Patten BM.
    Ann Intern Med; 1975 Mar 01; 82(3):411-5. PubMed ID: 123143
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.